FDA, Barr Pharmaceuticals, Inc. (BRL) To Meet August 8 On Morning-After Pill  
8/2/2006 10:18:09 AM

Barr Pharmaceuticals Inc. and the U.S. Food and Drug Administration are scheduled to meet Tuesday to discuss the company's bid to sell its morning-after contraceptive Plan B without a prescription, the agency said on Wednesday.